Dysregulation of MAP2 is associated with tauopathies, given that MAP2 shares sequences homology with tau and can inhibit its aggregation by binding to the ends of the tau fibrils (Zhang and Dong, 2012; Holden et al., 2023). The gene discussed is MAPT; the disease is tauopathy.